SIGN IN
2026 Summer Intern | Pulmonary Drug Discovery jobs in United States
cer-icon
Apply on Employer Site
company-logo

Ionis Pharmaceuticals, Inc. · 1 day ago

2026 Summer Intern | Pulmonary Drug Discovery

Ionis Pharmaceuticals, Inc. is a leader in RNA-targeted medicines, dedicated to discovering medical breakthroughs for serious diseases. They are seeking a Summer Intern in Pulmonary Drug Discovery to support a preclinical project comparing RNA-therapeutic strategies for non-cystic fibrosis bronchiectasis using established mouse models and molecular endpoints.
BiotechnologyHealth CareMedicalPharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

Execute and help optimize an NCFB-like mouse model protocol (building on published/internal methods) and ensure proper controls and documentation
Support in vivo study activities (rodent handling, dosing, tissue collection) following SOPs and animal welfare requirements
Process samples (tissue homogenization, RNA extraction) and quantify key markers of inflammation and muco-obstruction using qPCR, ELISA or related assays
Organize/analyze data and communicate results via weekly updates and a final summary/presentation

Qualification

RNA extractionQPCRELISARodent handlingData analysis

Required

MUST be currently enrolled in a U.S. Undergraduate and/or Graduate Degree Program and not graduating prior to the completion of the Ionis internship
MUST be able to begin internship between 6/8 and 8/14/2026
MUST be able and willing to remain in program through at least 8/14/2026
MUST be able and willing to commit to a minimum 40-hour work week

Benefits

Weekly stipend (for onsite interns only)
Housing/Travel assistance available for eligible, out-of-area interns
Professional Networking
End-of-program project presentations
Networking and bonding social events
Interaction with diverse and motivated teams/departments

Company

Ionis Pharmaceuticals, Inc.

company-logo
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases.

H1B Sponsorship

Ionis Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (8)
2024 (5)
2023 (3)
2022 (5)
2021 (5)
2020 (1)

Funding

Current Stage
Public Company
Total Funding
$2.45B
2025-11-13Post Ipo Debt· $700M
2024-09-09Post Ipo Equity· $500.3M
2023-06-06Post Ipo Debt· $500M

Leadership Team

leader-logo
Brett P. Monia
Chief Executive Officer
linkedin
leader-logo
Eric Bastings
Senior Vice President, Development Strategy
linkedin
Company data provided by crunchbase